- Asked by: Mark Ruskell, MSP for Mid Scotland and Fife, Scottish Green Party
-
Date lodged: Friday, 13 August 2004
-
Current Status:
Answered by Malcolm Chisholm on 7 September 2004
To ask the Scottish Executive, further to the answers to questions S2W-9592 and S2W-9593 by Malcolm Chisholm on 29 July 2004, what information it has on when the (a) United Kingdom Ethics Committee Authority and (b) Central Office for Research Ethics Committees have requested from the Edinburgh Independent Ethics Committee for Medical Research (i) a list of their members and (ii) declarations of interests of those members.
Answer
I refer the member to the answer to question S2W–10016 on 7 September 2004. All answers to written parliamentary questions are available on the Parliament’s website, the search facility for which can be found at
http://www.scottish.parliament.uk/webapp/search_wa.
- Asked by: Mark Ruskell, MSP for Mid Scotland and Fife, Scottish Green Party
-
Date lodged: Friday, 13 August 2004
-
Current Status:
Answered by Malcolm Chisholm on 7 September 2004
To ask the Scottish Executive, further to the answer to question S2W-9595 by Malcolm Chisholm on 29 July 2004, whether Schedule 2, or any other part of The Medicines for Human Use (Clinical Trials) Regulations, covers clinical trials of non-pharmaceutical substances on healthy volunteers.
Answer
The Medicines for Human Use (Clinical Trials) Regulations 2004 apply only to clinical trials of medicinal products. Substances falling outwith that definition would, therefore, not be in covered by the Regulations. The definition of “medicinal product” is set out in section 2 of the Regulations.
- Asked by: Mark Ruskell, MSP for Mid Scotland and Fife, Scottish Green Party
-
Date lodged: Friday, 13 August 2004
-
Current Status:
Answered by Malcolm Chisholm on 7 September 2004
To ask the Scottish Executive, further to the answer to question S2W-9594 by Malcolm Chisholm on 29 July 2004, what criteria under the Clinical Trials Directive (a) NHS and (b) non-NHS ethics committees have to fulfil before they can be given type (1) recognition by the United Kingdom Ethics Committee Authority.
Answer
The criteria applicable to all committees are set out in Regulation 7 of, and Schedule 2 to, The Medicines for Human Use (Clinical trials) Regulations 2004. Committees recognised solely for the purpose of Phase 1 trials, however, are not required to meet the provisions set out in Schedule 2 until 1 May 2005.
- Asked by: Mark Ruskell, MSP for Mid Scotland and Fife, Scottish Green Party
-
Date lodged: Friday, 13 August 2004
-
Current Status:
Answered by Malcolm Chisholm on 7 September 2004
To ask the Scottish Executive, further to the answer to question S2W-9594 by Malcolm Chisholm on 29 July 2004, whether the informed consent, with full information given about treatment, of healthy volunteers participating in human clinical trials of non-pharmaceutical substances is required under the Clinical Trials Directive.
Answer
The Clinical Trials Directive, which was transposed into UK law by The Medicines for Human Use (Clinical Trials) Regulations 2004, addresses clinical trials of medicinal products (that will include some non-pharmaceutical substances) and requires fully informed consent.
- Asked by: Mark Ruskell, MSP for Mid Scotland and Fife, Scottish Green Party
-
Date lodged: Friday, 13 August 2004
-
Current Status:
Answered by Malcolm Chisholm on 7 September 2004
To ask the Scottish Executive, further to the answers to questions S2W-9592 and S2W-9593 by Malcolm Chisholm on 29 July 2004, whether the (a) Ethics Committee Authority or (b) Central Office for Research Ethics Committees holds (i) the list of members of the Edinburgh Independent Ethics Committee for Medical Research and (ii) declarations of interests of those members.
Answer
This information has not been requested nor is it held by UK Ethics Committee Authority or Central Office Research Ethics Committees.
- Asked by: Mark Ruskell, MSP for Mid Scotland and Fife, Scottish Green Party
-
Date lodged: Thursday, 24 June 2004
-
Current Status:
Answered by Allan Wilson on 20 August 2004
To ask the Scottish Executive to what terms and conditions the farm scale evaluations of genetically modified crops were subject.
Answer
I refer the member to the answer given to question S2W-9329 on 20 August 2004. All answers to written parliamentary questions are available on the Parliament’s website, the search facility for which can be found at
http://www.scottish.parliament.uk/webapp/search_wa.
- Asked by: Mark Ruskell, MSP for Mid Scotland and Fife, Scottish Green Party
-
Date lodged: Thursday, 24 June 2004
-
Current Status:
Answered by Allan Wilson on 20 August 2004
To ask the Scottish Executive whether comparisons between Scottish and English farm scale evaluations of genetically modified crops were valid if they were conducted under different terms and conditions.
Answer
I refer the member to the answer given to question S2W-9329 on 20 August 2004. All answers to written parliamentary questions are available on the Parliament’s website, the search facility for which can be found at
http://www.scottish.parliament.uk/webapp/search_wa.
- Asked by: Mark Ruskell, MSP for Mid Scotland and Fife, Scottish Green Party
-
Date lodged: Thursday, 24 June 2004
-
Current Status:
Answered by Allan Wilson on 20 August 2004
To ask the Scottish Executive whether the terms and conditions under which the farm scale evaluations of genetically modified crops were carried out were applied rigorously.
Answer
I refer the member to the answer given to question S2W-9329 on 20 August 2004. All answers to written parliamentary questions are available on the Parliament’s website, the search facility for which can be found at
http://www.scottish.parliament.uk/webapp/search_wa.
- Asked by: Mark Ruskell, MSP for Mid Scotland and Fife, Scottish Green Party
-
Date lodged: Thursday, 24 June 2004
-
Current Status:
Answered by Allan Wilson on 20 August 2004
To ask the Scottish Executive, further to the answer to question S1W-741 by Ross Finnie on 7 September 1999, whether farm scale evaluations of genetically modified crops were conducted according to Supply Chain Initiative on Modified Agricultural Crop guidelines.
Answer
The SCIMAC guidelines are guidelines only, developed by the industry themselves to facilitate the management of herbicide resistant GM crops. As such they were not legally binding on farmers participating in the Farm Scale Evaluations; either in Scotland, or elsewhere in the UK. It was, however, our clear expectationthat farmers would follow these voluntary guidelines. We are satisfied that, asfar as possible, they did so.
The SCIMAC guidelines are entirely separate from the consent which is required before any GMO can legally be released. Consents - including the limitations and conditions set out within them - are legally binding. The terms and conditions for trial consents in Scotland were based on the advice of our statutory Advisory Committee on Release to the Environment and were the same as those in England in all material respects. Copies have been placed in the Scottish Parliament’s Reference Centre (Bib. number 33245).
Compliance with the consents was monitored and enforced by the Executive’s GM Inspectorate.
- Asked by: Mark Ruskell, MSP for Mid Scotland and Fife, Scottish Green Party
-
Date lodged: Thursday, 24 June 2004
-
Current Status:
Answered by Allan Wilson on 20 August 2004
To ask the Scottish Executive whether the farm scale evaluations of genetically modified crops carried out in Scotland were conducted under the same terms and conditions as those carried out in England.
Answer
I refer the member to the answer given to question S2W-9329 on 20 August 2004. All answers to written parliamentary questions are available on the Parliament’s website, the search facility for which can be found at
http://www.scottish.parliament.uk/webapp/search_wa.
